MCID: GLL017
MIFTS: 47

Gallbladder Adenocarcinoma malady

Summaries for Gallbladder Adenocarcinoma

About this section
Sources:
32MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
MalaCards: Gallbladder Adenocarcinoma, also known as adenocarcinoma of the gallbladder, is related to adenocarcinoma and papillary adenocarcinoma. An important gene associated with Gallbladder Adenocarcinoma is MUC2 (mucin 2, oligomeric mucus/gel-forming), and among its related pathways are IL-3 Signaling Pathway and TGF-Beta Pathway. The compounds butyrate and o-tyrosine have been mentioned in the context of this disorder. Affiliated tissues include lymph node, colon and liver, and related mouse phenotypes are embryogenesis and integument.

Aliases & Classifications for Gallbladder Adenocarcinoma

About this section
Sources:
8Disease Ontology, 60UMLS, 39NCIt
See all sources

Aliases & Descriptions:

gallbladder adenocarcinoma 8 60
adenocarcinoma of the gallbladder 8


External Ids:

Disease Ontology8 DOID:3500
NCIt39 C9166

Related Diseases for Gallbladder Adenocarcinoma

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases related to Gallbladder Adenocarcinoma via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 131)
idRelated DiseaseScoreTop Affiliating Genes
1adenocarcinoma31.3JAK2, CHGA, MYC, TYMP, MUC2, MUC1
2papillary adenocarcinoma30.5MUC2, MUC1, NME1
3gallbladder cancer30.4KRAS, MUC2
4large cell carcinoma30.4CHGA, KRAS, ERBB2
5gastric adenocarcinoma30.2CHGA, MYC, TYMP, MUC2, NME1, KRAS
6pneumonia30.2MUC1
7hepatitis30.2TYMP, KRAS
8hepatocellular carcinoma30.1TYMP, MUC2, CD82, NME1, KRAS, PTK2B
9gastrointestinal stromal tumor30.0IFI27
10hypertension30.0SELE
11signet ring cell adenocarcinoma30.0CHGA, MUC2
12adenosquamous carcinoma30.0NME1, MUC1, MUC2, TYMP, CHGA
13ulcerative colitis30.0MUC2, SRC, LAMC2, SELE
14leukemia29.9IFI27, SOAT1, JAK2, MYC, TYK2, CD82
15adenoma29.9MUC2, MYC, CHGA, IFI27, BRAF, MUC1
16neuroendocrine carcinoma10.4
17acanthosis nigricans10.3
18cholecystitis10.2
19xanthogranulomatous cholecystitis10.1
20acute interstitial pneumonia10.1
21gallbladder small cell carcinoma10.1
22gallbladder pleomorphic giant cell adenocarcinoma10.1
23small cell carcinoma10.1
24choledochal cyst10.1
25bile duct mucinous adenocarcinoma10.1
26bile duct adenocarcinoma10.1
27acalculous cholecystitis10.0
28gallbladder signet ring cell adenocarcinoma10.0
29adenosquamous gallbladder carcinoma10.0
30mucinous adenocarcinoma10.0
31sclerosing cholangitis10.0
32cholangitis10.0
33chronic lymphocytic leukemia10.0
34meningitis10.0
35ampulla of vater neoplasm10.0MUC2
36pancreatitis10.0KRAS
37endometriosis10.0TYMP
38leiomyoma10.0TYMP
39ductal carcinoma in situ10.0ERBB2
40neurofibromatosis10.0KRAS
41gastritis10.0CHGA
42rhabdoid tumor10.0MUC1
43angiosarcoma10.0MUC1
44laryngeal squamous cell carcinoma10.0NME1, IFI27
45biliary papillomatosis10.0MUC2
46oral cancer10.0CD82, IFI27
47myelofibrosis10.0JAK2
48juvenile myelomonocytic leukemia10.0KRAS
49leiomyosarcoma10.0MUC1
50cervical squamous cell carcinoma10.0KRAS, TYMP

Graphical network of the top 20 diseases related to Gallbladder Adenocarcinoma:



Diseases related to gallbladder adenocarcinoma

Clinical Features for Gallbladder Adenocarcinoma

About this section

Drugs & Therapeutics for Gallbladder Adenocarcinoma

About this section
Sources:
5CenterWatch, 41NIH Clinical Center, 6ClinicalTrials
See all sources

Approved drugs:

Search CenterWatch for Gallbladder Adenocarcinoma

Drug clinical trials:

Search ClinicalTrials for Gallbladder Adenocarcinoma

Search NIH Clinical Center for Gallbladder Adenocarcinoma

Search CenterWatch for Gallbladder Adenocarcinoma

Genetic Tests for Gallbladder Adenocarcinoma

About this section

Anatomical Context for Gallbladder Adenocarcinoma

About this section
Sources:
32MalaCards
See all sources

MalaCards organs/tissues related to Gallbladder Adenocarcinoma:

32
Lymph node, Colon, Liver

Animal Models for Gallbladder Adenocarcinoma or affiliated genes

About this section
Sources:
36MGI
See all sources

MGI Mouse Phenotypes related to Gallbladder Adenocarcinoma:

36 (show all 15)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000538010.3ERBB2
2MP:001077110.1SOAT1, MYC, NME1, KRAS
3MP:000539010.0JAK2, MYC, TYK2, LAMC2
4MP:00053799.8SOAT1, JAK2, MYC, MUC2, NME1, KRAS
5MP:00053769.8SOAT1, TYK2, MUC2, MCAM, PTK2B, SELE
6MP:00053819.5BRAF, MYC, MUC2, MUC1, KRAS, LAMC2
7MP:00053709.5BRAF, SOAT1, MYC, MUC1, NME1, KRAS
8MP:00036319.3MYC, TYMP, EPHA7, NME1, SRC, ERBB2
9MP:00020069.3ERBB2, BRAF, SOAT1, JAK2, MYC, MUC2
10MP:00053979.2MYC, JAK2, SOAT1, BRAF, TYK2, MUC2
11MP:00053859.1BRAF, SOAT1, CHGA, MYC, MUC2, MCAM
12MP:00107689.0TYK2, MYC, CHGA, JAK2, BRAF, MUC2
13MP:00053788.9BRAF, JAK2, CHGA, MYC, MUC2, NME1
14MP:00053848.9BRAF, SOAT1, JAK2, MYC, TYMP, TYK2
15MP:00053878.7BRAF, SOAT1, JAK2, MYC, TYMP, TYK2

Publications for Gallbladder Adenocarcinoma

About this section
Sources:
50PubMed
See all sources

Articles related to Gallbladder Adenocarcinoma:

(show top 50)    (show all 106)
idTitleAuthorsYear
1
ACE2 and FZD1 are prognosis markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of gallbladder. (23921915)
2014
2
Gastrointestinal Stromal Tumor with Synchronous Gallbladder Adenocarcinoma. (23749654)
2013
3
Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma. (23782473)
2013
4
Secondary Sclerosing Cholangitis due to Gallbladder Adenocarcinoma. (23626514)
2013
5
ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder. (23065574)
2013
6
Expression of p53 upregulated modulator of apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their pathological significance. (23475628)
2013
7
Squamous variant of gallbladder cancer: is it different from adenocarcinoma? (23827515)
2013
8
Expression of MUC1 and MUC4 in gallbladder adenocarcinoma. (23136569)
2012
9
Up-regulation of galectin-3 and Sambucus nigra agglutinin binding site is associated with invasion, metastasis and poor-progression of the gallbladder adenocarcinoma. (22497866)
2012
10
Frequency of genetic alterations observed in cell cycle regulatory proteins and microsatellite instability in gallbladder adenocarcinoma: a translational perspective. (21545232)
2011
11
Metastatic gallbladder adenocarcinoma with signet-ring cells: A case report. (21917161)
2011
12
Gallbladder adenocarcinoma with extended intramural spread in adenomyomatosis of the gallbladder with the pearl necklace sign. (21375832)
2011
13
Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma. (21719208)
2011
14
Curative resection of combined neuroendocrine carcinoma and adenocarcinoma of the gallbladder. (22322853)
2011
15
Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder. (20040392)
2010
16
National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis. (20824371)
2010
17
Combined large cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder. (19945229)
2010
18
Gene amplification of Myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinoma. (19331129)
2009
19
Schedule-dependent synergistic interaction between gemcitabine and oxaliplatin in human gallbladder adenocarcinoma cell lines. (19209029)
2009
20
Correlation of aberrant expression of p53, Rad50, and cyclin-E proteins with microsatellite instability in gallbladder adenocarcinomas. (19866438)
2009
21
Spontaneous necrosis of solid gallbladder adenocarcinoma accompanied with pancreaticobiliary maljunction. (18855999)
2008
22
Gallbladder adenocarcinoma arising in Rokitansky-Aschoff sinus. (19067858)
2008
23
The impact of tumor extent (T stage) and lymph node involvement (N stage) on survival after surgical resection for gallbladder adenocarcinoma. (19088928)
2008
24
Expression of nm23 and KAI1 and their clinical significance in gallbladder adenocarcinoma]. (19024519)
2008
25
Gallbladder adenocarcinoma: first report in a patient with AIDS. (18441163)
2008
26
Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinoma. (18065642)
2007
27
Gefitinib, a selective EGFR tyrosine kinase inhibitor, induces apoptosis through activation of Bax in human gallbladder adenocarcinoma cells. (16229013)
2006
28
Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells. (16532343)
2006
29
A comparative clinical study of gallbladder tubular adenocarcinoma according to the grade of differentiation. (15549451)
2004
30
Protease-activating-receptor-2 is frequently expressed in papillary adenocarcinoma of the gallbladder. (15492786)
2004
31
Case of mucinous adenocarcinoma with porcelain gallbladder. (12859733)
2003
32
Mucinous adenocarcinoma originating in localized type adenomyomatosis of the gallbladder. (11780399)
2001
33
Value of CEA level determination in gallbladder bile in the diagnosis of liver metastases secondary to colorectal adenocarcinoma. (11391453)
2001
34
Hepatoid adenocarcinoma of the gallbladder. (10982619)
2000
35
Gallbladder Adenocarcinoma with Florid Neuroendocrine Cell Nests and Extensive Paneth Cell Metaplasia. (12114761)
2000
36
v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells. (10048975)
1999
37
High frequency of p53 gene mutation in adenocarcinomas of the gallbladder. (8781743)
1996
38
Differentiation towards gastric foveolar, mucopeptic and intestinal goblet cells in gallbladder adenocarcinomas. (8951489)
1996
39
Expression of the proliferative cell nuclear antigen (PCNA) in adenocarcinoma of the gallbladder, and its relationship to prognosis. (8545595)
1995
40
Xanthogranulomatous cholecystitis associated with gallbladder adenocarcinoma. A clinicopathological study of 5 cases. (1746061)
1991
41
DNA ploidy patterns in gallbladder adenocarcinoma. (2319702)
1990
42
Morphometric analysis of gallbladder adenocarcinoma: discrimination between carcinoma and dysplasia. (2512741)
1989
43
A human gallbladder adenocarcinoma cell line. (2680052)
1989
44
Dysplasia of the gallbladder. Its histogenesis and correlation to gallbladder adenocarcinoma. (2602218)
1989
45
Gallbladder adenocarcinoma: the prognostic significance of histologic grade. (3807370)
1987
46
Gallbladder adenocarcinoma: prognostic significance of tumor acid mucopolysaccharide content. (2946897)
1986
47
Squamous cell carcinoma of the gallbladder associated with squamous metaplasia and adenocarcinoma in situ of the mucosal columnar epithelium. (3825536)
1986
48
Calcifying mucinous adenocarcinoma of the gallbladder. (4350100)
1973
49
Triplication of the gallbladder with cholecystitis, cholelithiasis, and papillary adenocarcinoma. (5089579)
1971
50
Primary papillary adenocarcinoma of the fundus of the gallbladder. (18110755)
1949

Genetic Variations for Gallbladder Adenocarcinoma

About this section

Expression for genes affiliated with Gallbladder Adenocarcinoma

About this section
Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Gallbladder Adenocarcinoma

Search GEO for disease gene expression data for Gallbladder Adenocarcinoma.

Pathways for genes affiliated with Gallbladder Adenocarcinoma

About this section
Sources:
37NCBI BioSystems Database, 51QIAGEN, 12EMD Millipore, 53Reactome, 29KEGG, 4Cell Signaling Technology, 55SinoBiological, 49PharmGKB, 52R&D Systems
See all sources

Pathways related to Gallbladder Adenocarcinoma according to GeneCards/GeneDecks:

(show top 50)    (show all 66)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
110.2SRC, TYK2
2
Hide members
10.2ERBB2, EPHA7
3
Hide members
10.1PTK2B, SRC
410.1SRC, LAMC2, ERBB2
510.0SRC, TYK2, JAK2
610.0JAK2, TYK2, SRC
710.0SRC, TYK2, JAK2
810.0TYK2, MYC, JAK2
910.0JAK2, MYC, TYK2
10
Hide members
10.0SRC, KRAS, BRAF
1110.0KRAS, MYC, BRAF
12
Development EPO-induced Jak-STAT pathway
Hide members
10.0SRC, MYC, JAK2
1310.0JAK2, TYK2, PTK2B
1410.0JAK2, KRAS, PTK2B
1510.0SRC, PTK2B, ERBB2
169.9PTK2B, SRC, JAK2
17
Hide members
9.9JAK2, KRAS, SRC, ERBB2
189.9JAK2, MUC1, SRC, ERBB2
19
Hide members
9.9JAK2, TYK2, KRAS, PTK2B
20
Hide members
9.9ERBB2, KRAS, MYC, BRAF
219.8JAK2, TYK2, PTK2B, ERBB2
22
Hide members
9.8KRAS, SRC, PTK2B, ERBB2
239.8BRAF, JAK2, MYC, SRC
24
Hide members
9.8PTK2B, SRC, KRAS, MYC
25
Immune response IFN gamma signaling pathway
Hide members
9.8JAK2, MYC, SRC, PTK2B
269.7BRAF, MYC, KRAS, LAMC2, ERBB2
27
Hide members
9.7BRAF, MYC, TYMP, KRAS, SRC
28
Hide members
9.7BRAF, JAK2, KRAS, SRC, SELE
29
Development Prolactin receptor signaling
Hide members
9.7JAK2, MYC, KRAS, SRC, ERBB2
309.7BRAF, MYC, KRAS, SRC, ERBB2
31
Hide members
9.7BRAF, MYC, KRAS, SRC, ERBB2
32
Hide members
9.7ERBB2, SRC, KRAS, MYC, BRAF
33
Development PDGF signaling via STATs and NF-kB
Hide members
9.7JAK2, MYC, TYK2, SRC, PTK2B
34
Hide members
9.7BRAF, JAK2, MYC, SRC, ERBB2
35
Hide members
9.7BRAF, SRC, LAMC2, PTK2B, ERBB2
36
Hide members
9.7IFI27, JAK2, TYK2, KRAS, PTK2B
379.6PTK2B, SRC, KRAS, MYC, JAK2
38
Hide members
9.6BRAF, JAK2, KRAS, SRC, PTK2B
39
Hide members
9.6PTK2B, SRC, KRAS, JAK2, BRAF
40
Hide members
9.6BRAF, JAK2, SRC, PTK2B, ERBB2
41
Hide members
9.6JAK2, MYC, TYK2, EPHA7, SRC, ERBB2
429.6MYC, CD82, NME1, KRAS, SRC, ERBB2
43
G-protein signaling Ras family GTPases in kinase cascades (scheme)
Hide members
9.5BRAF, JAK2, TYK2, KRAS, SRC, PTK2B
44
Hide members
9.5BRAF, JAK2, MYC, MUC1, SRC, ERBB2
45
Translation Insulin regulation of translation
Hide members
9.5BRAF, JAK2, KRAS, SRC, PTK2B, ERBB2
46
Hide members
9.5BRAF, JAK2, MYC, SRC, LAMC2, PTK2B
47
Hide members
9.5BRAF, MYC, KRAS, SRC, PTK2B, ERBB2
48
Hide members
9.4PTK2B, BRAF, JAK2, MYC, TYK2, MUC1
49
Hide members
9.3BRAF, JAK2, MYC, EPHA7, SRC, PTK2B
50
Hide members
9.1BRAF, JAK2, MYC, MUC1, EPHA7, SRC

Compounds for genes affiliated with Gallbladder Adenocarcinoma

About this section
Sources:
44Novoseek, 49PharmGKB, 59Tocris Bioscience, 11DrugBank, 28IUPHAR, 24HMDB, 2BitterDB
See all sources

Compounds related to Gallbladder Adenocarcinoma according to GeneCards/GeneDecks:

(show top 50)    (show all 124)
idCompoundScoreTop Affiliating Genes
1butyrate4410.5JAK2
2o-tyrosine4410.3TYK2, ERBB2, JAK2
3crcs4410.1MUC2, MUC1, NME1, KRAS, TYMP, BRAF
4etoposide44 49 59 1113.1ERBB2, CHGA, SELE, PTK2B
5cycloheximide4410.1TYMP
6gemcitabine44 49 1112.0MYC, TYMP, MUC1, SRC, ERBB2
7matrigel4410.0SRC, NME1, SELE, MUC1, JAK2, BRAF
8erlotinib44 49 1112.0ERBB2, SRC, TYMP, KRAS
9vanadate4410.0SOAT1, PTK2B, SRC, TYK2, JAK2
10sodium orthovanadate44 5911.0TYK2, JAK2, PTK2B, SRC
11dexamethasone44 49 28 1112.9PTK2B, NME1, MUC2, MYC, SOAT1, IFI27
12folate449.9SELE, ERBB2, PTK2B, MUC1, TYMP, MYC
13p002449.9CHGA, ERBB2, KRAS, NME1, TYMP, IFI27
14dmso449.8CHGA, MYC, SELE, MUC2, MUC1, PTK2B
15herbimycin a44 5910.8SRC, JAK2, MYC, SELE, PTK2B, ERBB2
16aspirin44 49 28 2412.8PTK2B, TYMP, ERBB2, SELE, JAK2, SRC
1712-o-tetradecanoylphorbol 13-acetate449.8BRAF, JAK2, CHGA, TYMP, MUC2, MUC1
18serine449.7ERBB2, JAK2, MUC2, NME1, KRAS, SRC
19adp44 28 2411.7PTK2B, NME1, EPHA7, TYK2, JAK2
20guanine44 11 2411.7IFI27, SELE, ERBB2, PTK2B, SRC, TYMP
21phosphotyrosine449.7PTK2B, SOAT1, ERBB2, TYK2, SRC, JAK2
22sb 20358044 5910.7SELE, BRAF, PTK2B, JAK2, SRC, MUC2
23tamoxifen44 49 28 1112.7SELE, ERBB2, TYMP, MUC1, MYC, CHGA
24paclitaxel44 49 1111.6BRAF, IFI27, SRC, TYMP, ERBB2, CHGA
255fluorouracil449.6MUC2, SRC, KRAS, PTK2B, ERBB2, SELE
26agar449.6BRAF, MUC1, JAK2, MYC, NME1, SRC
27genistein44 28 59 2 11 2414.6PTK2B, SRC, JAK2, IFI27, SELE, MYC
28actinomycin d449.6MUC2, SOAT1, JAK2, PTK2B, MUC1, TYMP
29thymidine44 2410.6NME1, TYMP, MUC1, IFI27, MYC, PTK2B
30phosphoinositide449.6BRAF, IFI27, SOAT1, JAK2, KRAS, SRC
31imatinib44 49 1111.6ERBB2, PTK2B, SRC, KRAS, MYC, JAK2
32n acetylcysteine449.5SRC, ERBB2, PTK2B, MYC, JAK2, SOAT1
33progesterone44 59 28 11 2413.5NME1, BRAF, TYMP, IFI27, MUC2, CHGA
34pd 98,059449.5BRAF, SOAT1, MYC, MUC2, SRC, JAK2
35wortmannin449.5TYMP, ERBB2, PTK2B, BRAF, SOAT1, JAK2
36testosterone44 59 11 2412.5IFI27, SOAT1, CHGA, SRC, PTK2B, SELE
37oligonucleotide449.4IFI27, BRAF, JAK2, CHGA, SOAT1, MYC
38cysteine449.4MUC2, NME1, SRC, TYMP, JAK2, PTK2B
39rapamycin449.4ERBB2, BRAF, IFI27, SOAT1, JAK2, MYC
40paraffin449.3MYC, TYMP, KRAS, ERBB2, MUC2, MUC1
41Adenosine triphosphate11 2410.3JAK2, TYK2, EPHA7, NME1, SRC, PTK2B
42alanine449.3PTK2B, SOAT1, JAK2, MYC, TYK2, NME1
43threonine449.2SOAT1, JAK2, MYC, TYK2, MUC2, MUC1
44phosphatidylinositol449.2BRAF, SOAT1, JAK2, MYC, TYK2, KRAS
45cyclic amp44 2410.1BRAF, IFI27, SOAT1, CHGA, MUC1, MCAM
46ly294002449.1MYC, BRAF, IFI27, JAK2, TYMP, TYK2
47cisplatin44 49 59 1112.1SRC, TYMP, MYC, CHGA, JAK2, IFI27
48retinoic acid44 2410.1NME1, PTK2B, MYC, KRAS, MUC1, CHGA
49vegf448.7BRAF, IFI27, SOAT1, JAK2, SELE, PTK2B
50tyrosine448.3MYC, MCAM, ERBB2, BRAF, IFI27, SOAT1

GO Terms for genes affiliated with Gallbladder Adenocarcinoma

About this section
Sources:
16Gene Ontology
See all sources

Cellular components related to Gallbladder Adenocarcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1caveolaGO:00590110.0SELE, SRC, JAK2
2membrane raftGO:0451219.5SELE, PTK2B, KRAS, JAK2

Biological processes related to Gallbladder Adenocarcinoma according to GeneCards/GeneDecks:

(show all 16)
idNameGO IDScoreTop Affiliating Genes
1enzyme linked receptor protein signaling pathwayGO:00716710.3ERBB2, JAK2
2activation of MAPKK activityGO:00018610.3KRAS, JAK2, BRAF
3positive regulation of epithelial cell proliferationGO:05067910.3MYC, NME1, ERBB2
4signal complex assemblyGO:00717210.3PTK2B, SRC
5peptidyl-tyrosine phosphorylationGO:01810810.2JAK2, SRC, PTK2B
6regulation of ERK1 and ERK2 cascadeGO:07037210.2ERBB2, EPHA7
7MAPK cascadeGO:00016510.2PTK2B, KRAS, MYC
8fibroblast growth factor receptor signaling pathwayGO:00854310.1BRAF, KRAS, SRC, ERBB2
9positive regulation of nitric-oxide synthase activityGO:05100010.1PTK2B, KRAS
10protein autophosphorylationGO:04677710.1JAK2, SRC, PTK2B, ERBB2
11epidermal growth factor receptor signaling pathwayGO:00717310.1ERBB2, PTK2B, SRC, KRAS
12cytokine-mediated signaling pathwayGO:01922110.1IFI27, JAK2, TYK2, KRAS
13protein phosphorylationGO:00646810.0ERBB2, PTK2B, TYK2, JAK2, BRAF
14intracellular protein kinase cascadeGO:0072439.9JAK2, TYK2, SRC
15neurotrophin TRK receptor signaling pathwayGO:0480119.9BRAF, KRAS, SRC, ERBB2
16positive regulation of ERK1 and ERK2 cascadeGO:0703749.6PTK2B, SRC, BRAF

Molecular functions related to Gallbladder Adenocarcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1growth hormone receptor bindingGO:00513110.2TYK2, JAK2
2non-membrane spanning protein tyrosine kinase activityGO:0047159.8JAK2, TYK2, SRC, PTK2B
3protein tyrosine kinase activityGO:0047139.6ERBB2, PTK2B, SRC, EPHA7, TYK2, JAK2
4ATP bindingGO:0055249.0BRAF, JAK2, TYK2, EPHA7, NME1, SRC
5protein bindingGO:0055158.1BRAF, SOAT1, JAK2, MYC, TYK2, MUC2

Products for genes affiliated with Gallbladder Adenocarcinoma

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Gallbladder Adenocarcinoma

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
50PubMed
51QIAGEN
57SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet